We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Leading Israeli generic drugmaker Teva has obtained final US FDA
approval on its ANDA for amoxicillin and clavulanate potassium chewable tablets,
at the 200mg/28.5mg and 400mg/57mg dosages.
Medium-sized Indian drugmaker Orchid claims to have begun talks with
multinational firms on licensing its new molecule for diabetes, known as BLX-1002.
Reports in the Indian business media indicate that the country's
leading drug producer, Ranbaxy Laboratories, is to bid for the pharmaceuticals
business of US-based Andrx Corporation.
As pharmaceutical sector development in Oman has been broadly based
around government cost-containment efforts in recent years, the country has
increasingly encouraged the private sector to shoulder more of the burden of
healthcare.
A presidential decree to authorise the sale of drugs at the
exact prescribed dose, which would involve splitting packets into smaller batches,
has been under recent discussion in Brazil's Congress.
Hungarian drug manufacturer Egis, an affiliate of France's Servier,
has announced expansion plans and reported its financial results for the 2003/04
year, October 1 through September 30.